Shots:

• Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI)
• The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance
• The study focuses to identify digital biomarkers to aid monitor cognitive performance and health including potentially detecting mild cognitive impairment- an early indicator of certain forms of dementia such as AD

 ­ Ref: Biogen | Image: Biogen